Comprehensive Healthcare Systems Inc
CHS
TILT Holdings Inc
TILT
Westmount Minerals Corp
WMC
Athena Gold Corp
ATHA
Xigem Technologies Corp
XIGM
(Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -21.16%-155.89M | 57.22%-57.34M | -282.83%-245.36M | 52.49%176.01M | -144.25%-158.67M | -264.69%-128.66M | -2,488.36%-134.04M | 10.46%134.2M | 10.34%115.42M | 52.34%-64.96M |
Net income from continuing operations | 1,721.34%63.66M | 30.20%28.47M | -99.98%129K | -23.35%-64.95M | -93.40%39.71M | -92.85%3.5M | -70.44%21.87M | 170.28%672.06M | 92.47%-52.65M | 812.93%601.87M |
Operating gains losses | -62.96%-35.07M | 28.51%-15.69M | 82.84%-124.01M | 21.65%-55.81M | 94.82%-31.75M | 9.77%-21.52M | 14.23%-21.95M | -649.36%-722.49M | -649.39%-71.24M | -1,782.63%-613.15M |
Depreciation and amortization | -2.14%62.54M | -8.56%58.57M | -7.32%251.46M | -9.30%60.35M | -6.72%63.15M | -3.72%63.9M | -9.41%64.05M | -23.42%271.31M | -25.61%66.54M | -6.84%67.71M |
Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -102.24%-6.23M | ---- | ---- |
Remuneration paid in stock | -1,175.31%-34.54M | 14.07%-20.31M | -393.73%-78.15M | -106.58%-9M | 47.47%-48.73M | 111.64%3.21M | -330.35%-23.63M | -89.44%26.61M | -46.52%136.72M | -630.43%-92.77M |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | 63.32%-490K | ---- | ---- | ---- | ---- | -303.04%-1.34M |
Remuneration paid in stock | 375.34%18.27M | 48.97%19.57M | -53.57%17.09M | 259.01%3.36M | -54.33%7.22M | -125.33%-6.64M | 524.39%13.14M | 265.13%36.8M | -131.20%-2.12M | 192.78%15.81M |
Deferred tax | 128.98%7.96M | 192.69%11.58M | 59.03%-28.35M | -1.12%-38.48M | 129.02%2.7M | 113.87%3.48M | 22.48%3.96M | -1,838.44%-69.19M | -256.04%-38.05M | -120.61%-9.3M |
Other non cashItems | 118.24%6.5M | 284.18%44.4M | -4.70%55.66M | 1,373.75%80.07M | -77.52%10.23M | -162.37%-35.62M | 126.62%11.56M | 35.79%58.4M | -85.11%5.43M | 240.71%45.52M |
Change In working capital | -126.44%-190.32M | 18.94%-145.72M | -168.02%-260.57M | 384.05%184.67M | -222.26%-181.43M | -126.72%-84.05M | -328.02%-179.76M | -142.41%-97.22M | -82.47%38.15M | 53.29%-56.3M |
-Change in receivables | -41,886.52%-176.76M | -34.36%-269.28M | -35.42%-164.84M | 171.03%231.67M | 45.82%-196.53M | -99.78%423K | -455.94%-200.41M | -121.82%-121.72M | -63.55%85.48M | -396.96%-362.73M |
-Change in inventory | -26.95%-358K | -89.72%297K | 47.72%-492K | 57.95%-1.06M | -357.30%-2.04M | -115.76%-282K | 384.53%2.89M | -101.35%-941K | 23.67%-2.51M | -97.36%794K |
-Change in payables and accrued expense | -112.72%-32.99M | 42.36%96.38M | 133.38%21.21M | 88.00%-17.62M | -107.95%-13.37M | 88.41%-15.51M | 38.26%67.7M | 80.79%-63.53M | -6.64%-146.76M | 246.90%168.04M |
-Change in other current assets | 91.74%-1.1M | -89.44%-38.36M | -192.64%-100.74M | -415.79%-34.79M | -125.93%-32.4M | 61.93%-13.31M | -179.41%-20.25M | 274.20%108.74M | -104.55%-6.74M | 167.14%124.94M |
-Change in other current liabilities | 51.74%-29.98M | 22.72%-12M | -249.90%-19.53M | -8.53%41.27M | 632.88%16.86M | -39.35%-62.13M | -425.95%-15.53M | 52.25%-5.58M | 164.11%45.12M | 94.52%-3.16M |
-Change in other working capital | 653.35%50.87M | 645.42%77.24M | 126.95%3.82M | -154.77%-34.82M | 190.96%46.05M | 139.40%6.75M | 81.47%-14.16M | -308.53%-14.19M | 37.39%63.57M | 120.46%15.83M |
Dividends received (cash flow from operating activities) | -12.39%17.79M | 79.49%24.44M | -9.91%119.42M | -15.53%65.66M | -23.21%19.84M | -6.00%20.31M | 84.49%13.62M | 0.85%132.55M | 83.63%77.74M | -32.67%25.83M |
Interest paid (cash flow from operating activities) | -103.49%-53.19M | -58.78%-36.63M | -24.29%-120.58M | 1.72%-34.55M | -77.29%-36.82M | -126.61%-26.14M | 21.93%-23.07M | 7.61%-97.01M | -26.92%-35.16M | 7.07%-20.77M |
Tax refund paid | 60.29%-19.5M | -88.53%-26.03M | -8.49%-77.45M | -13.33%-12.25M | 91.82%-2.3M | -221.47%-49.1M | 19.88%-13.81M | -216.78%-71.39M | 12.78%-10.81M | -536.40%-28.08M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -21.16%-155.89M | 57.22%-57.34M | -282.83%-245.36M | 52.49%176.01M | -144.25%-158.67M | -264.69%-128.66M | -2,488.36%-134.04M | 10.46%134.2M | 10.34%115.42M | 52.34%-64.96M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -123.09%-58.6M | -71.80%-41.85M | 68.73%-82.47M | 170.39%36.33M | 35.62%-68.17M | 67.37%-26.27M | 5.25%-24.36M | -42.45%-263.71M | -24.40%-51.61M | -334.91%-105.88M |
Net PPE purchase and sale | -33.09%-26.1M | -4.18%-15.38M | -3.33%-109.83M | 28.32%-33.89M | -100.20%-41.56M | -0.30%-19.61M | 21.01%-14.77M | -40.19%-106.29M | -219.50%-47.29M | -28.11%-20.76M |
Net business purchase and sale | --0 | ---- | 530.83%69.26M | 1,299.46%69.97M | 96.62%-713K | --0 | ---- | -6.87%-16.08M | 166.09%5M | -181.84%-21.08M |
Net investment purchase and sale | --0 | --0 | -2.15%-27.79M | ---40.48M | 140.82%11.85M | -1,058.20%-13.62M | 3,543.58%14.47M | 51.28%-27.2M | --0 | -222.37%-29.02M |
Net other investing changes | -566.97%-32.5M | -10.01%-26.47M | 87.63%-14.12M | 536.89%40.73M | -7.75%-37.75M | 111.16%6.96M | -224.57%-24.06M | -197.04%-114.14M | 51.25%-9.32M | -520.23%-35.03M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -123.09%-58.6M | -71.80%-41.85M | 68.73%-82.47M | 170.39%36.33M | 35.62%-68.17M | 67.37%-26.27M | 5.25%-24.36M | -42.45%-263.71M | -24.40%-51.61M | -334.91%-105.88M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -3.25%209.71M | 62.51%88.47M | 247.05%283.12M | -592.91%-127.77M | 465.58%139.69M | 675.16%216.76M | 126.49%54.44M | -1.11%-192.54M | 109.23%25.92M | 108.89%24.7M |
Net issuance payments of debt | -3.17%213.22M | 58.69%91.98M | 266.57%300.16M | -565.36%-121.21M | 409.06%143.21M | 837.71%220.2M | 128.34%57.96M | -1.62%-180.2M | 109.28%26.05M | 110.32%28.13M |
Cash dividends paid | 0.00%-3.51M | 0.00%-3.51M | 0.00%-14.04M | 0.00%-3.51M | 0.00%-3.51M | 50.00%-3.51M | ---3.51M | 0.00%-14.04M | 0.00%-3.51M | 0.00%-3.51M |
Net other financing activities | ---- | ---- | -275.39%-3M | -190.05%-3.05M | -112.99%-10K | 108.47%69K | 98.83%-11K | 81.83%1.71M | 3.74%3.39M | 104.61%77K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -3.25%209.71M | 62.51%88.47M | 247.05%283.12M | -592.91%-127.77M | 465.58%139.69M | 675.16%216.76M | 126.49%54.44M | -1.11%-192.54M | 109.23%25.92M | 108.89%24.7M |
Net cash flow | ||||||||||
Beginning cash position | 10.92%561.3M | -6.61%570.28M | -34.55%610.61M | -7.16%482.58M | -14.41%567.38M | -27.99%506.02M | -34.55%610.61M | -21.51%932.9M | -54.82%519.77M | -58.34%662.91M |
Current changes in cash | -107.74%-4.78M | 89.69%-10.72M | 86.12%-44.71M | -5.77%84.56M | 40.37%-87.15M | 254.30%61.83M | 53.91%-103.96M | -26.76%-322.04M | 141.20%89.74M | 66.67%-146.15M |
Effect of exchange rate changes | -761.21%-4M | 375.08%1.74M | 1,866.53%4.38M | 183.74%3.14M | -22.25%2.34M | -260.55%-464K | 86.37%-634K | 85.11%-248K | 647.97%1.11M | 233.29%3.01M |
End cash Position | -2.62%552.52M | 10.92%561.3M | -6.61%570.28M | -6.61%570.28M | -7.16%482.58M | -14.41%567.38M | -27.99%506.02M | -34.55%610.61M | -34.55%610.61M | -54.82%519.77M |
Free cash from | -22.74%-181.99M | 51.13%-72.72M | -1,372.75%-355.19M | 108.57%142.11M | -133.58%-200.22M | -353.16%-148.28M | -1,037.45%-148.8M | -38.89%27.91M | -24.13%68.14M | 43.79%-85.72M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.